Skip to main content
. 2007 Sep;67(3):457–461. doi: 10.1111/j.1365-2265.2007.02911.x

Table 1.

Phenotype and genotype of NESTEGG short SGA (n = 240) and controls (n = 193). Data are presented as mean ± SD or percentage

SGA (n = 240) Controls (n = 193)
Phenotype
Sex ratio (M/F) 138/102
Birth length (SDS) –2·9 ± 1·4
Birthweight (SDS) –2·3 ± 1·0
Maternal height (SDS) –1·0 ± 1·3
Paternal height (SDS) –0·8 ± 1·0
Age at onset of GH treatment (years) 6·6 ± 2·3
Height at start of GH treatment (SDS) –3·0 ± 0·7
Weight at start of GH treatment (SDS) –2·4 ± 0·9
GH dose (mg/kg/week) 0·40 ± 0·17
Genotype
fl/fl, % (n) 60 (144) 51 (98)
fl/d3, % (n) 27 (65) 41 (80)
d3/d3, % (n) 13 (31) 8 (15)